Edition:
United States

Boston Scientific Corp (BSX)

BSX on New York Consolidated

25.97USD
26 Apr 2017
Change (% chg)

-- (--)
Prev Close
$25.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,820,334
52-wk High
$26.15
52-wk Low
$19.59

Select another date:

Tue, Apr 18 2017

BRIEF-Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy

* Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy in patients with diabetes who have previously experienced a heart attack

Boston Scientific to expand in Europe with Symetis buy

Boston Scientific Corp on Thursday agreed to buy Swiss medical device maker Symetis SA for $435 million, looking to bolster its presence in Europe after recalling a range of heart valves in the region.

UPDATE 3-Boston Scientific to expand in Europe with Symetis buy

* Symetis' Acurate devices complementary to Boston Scientific's Lotus valves

BRIEF-Symetis, Boston Scientific reach $435 mln purchase agreement

* Symetis and Boston Scientific reach USD 435 million purchase agreement

BRIEF-Boston Scientific agrees to acquire Symetis for $435 mln

* Boston Scientific Corp - deal for $435 million in up-front cash

Boston Scientific to acquire Symetis for $435 mln

March 30 Boston Scientific Corp said on Thursday it would buy privately-held Swiss medical device maker Symetis SA for $435 million to expand its business of making minimally invasive heart devices.

BRIEF-Boston Scientific CEO Michael Mahoney's FY 2016 total compensation was $12 mln vs $11.6 mln in FY 2015

* CEO Michael Mahoney's FY 2016 total compensation was $12.0 million versus $11.6 million in FY 2015 - sec filing Source text (http://bit.ly/2ny4bpM) Further company coverage:

BRIEF-German patent court issues initial decision

* District court in Germany ruled that Boston Scientific's lotus valve infringes one of co's patents for transcatheter aortic valves

BRIEF-Boston Scientific receives favorable rulings in Edwards Lifesciences litigation

* Boston scientific receives favorable rulings in edwards lifesciences litigation

BRIEF-Edwards Lifesciences says UK patent court issues decision on transcatheter heart valves

* Edwards Lifesciences Corp says company is not changing its financial guidance

Select another date:

More From Around the Web